Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Australia ETF (EWA) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance

iShares MSCI Australia ETFTrade
Indivior Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Australia ETF vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? iShares MSCI Australia ETF trades at $28.55 (market cap $1.20B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is far larger — about 3.5× iShares MSCI Australia ETF's market cap, and Indivior Pharmaceuticals Inc. Common Stock is more actively traded (1,819,746 versus 1,742,887). Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Australia ETF for 61 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.

EWAINDV
Market Cap
$1.20B$4.18B
Volume
1,742,8871,819,746
Sector
Broad Market / FactorHealth
52-Week High
$30.43$41.83
52-Week Low
$24.95$24.09
Typical Hold Time
61 Days0 Days
Enterprise Value
—$4.47B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Australia ETF

EWA, the iShares MSCI Australia ETF, trades at $28.77, up 0.35% today, but technical indicators signal a bearish trend with moving averages and key oscillators like the 6-day RSI at 75.94 suggesting overbought conditions. The ETF tracks Australian equities, heavily weighted toward commodities and financials, with recent news highlighting institutional selling by Squarepoint Ops LLC amid broader market concerns over inflation and oil price volatility.

The outlook for EWA hinges on commodity demand and global economic trends, offering exposure to Australia's resource-driven economy but facing risks from inflation and geopolitical tensions. Analyst sentiment is mixed, with Seeking Alpha rating it a Buy targeting over 20% upside, while technical weakness and institutional selling pose near-term headwinds.

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWA
100% Buy0% Sell
Avg holding period · 61 Days
INDV
100% Buy0% Sell
Avg holding period · 0 Days

About iShares MSCI Australia ETF

EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.

Read more on EWA →

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →